LAXMAN DEVKOTA to Humans
This is a "connection" page, showing publications LAXMAN DEVKOTA has written about Humans.
Connection Strength
0.082
-
Nanoparticle Contrast Agents for Photon-Counting Computed Tomography: Recent Developments and Future Opportunities. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025 Jan-Feb; 17(1):e70004.
Score: 0.026
-
Detection of response to tumor microenvironment-targeted cellular immunotherapy using nano-radiomics. Sci Adv. 2020 07; 6(28):eaba6156.
Score: 0.019
-
Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents. Bioorg Med Chem. 2016 Mar 01; 24(5):938-956.
Score: 0.014
-
Ferumoxytol-enhanced MRI of retroplacental clear space disruption in placenta accreta spectrum. Placenta. 2025 Feb; 160:100-106.
Score: 0.007
-
Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's disease. Sci Rep. 2020 09 30; 10(1):16185.
Score: 0.005
-
Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia. J Nat Prod. 2020 04 24; 83(4):937-954.
Score: 0.005
-
Structural interrogation of benzosuberene-based inhibitors of tubulin polymerization. Bioorg Med Chem. 2015 Dec 15; 23(24):7497-520.
Score: 0.003
-
Synthesis of structurally diverse benzosuberene analogues and their biological evaluation as anti-cancer agents. Bioorg Med Chem. 2013 Dec 15; 21(24):8019-32.
Score: 0.003